AlphaMadera's AlphaVal page classifies Photronics, Inc. as a Cyclical & Capital-Intensive business and values it using Normalized Earnings × Cycle Multiple, then compares the result to the current market price to flag PLAB as undervalued, fairly valued, or overvalued.

What is Photronics, Inc.'s fair value?

Fair value for PLAB comes from a Normalized Earnings × Cycle Multiple model -- the approach AlphaVal selected for this company's Cyclical & Capital-Intensive classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value PLAB?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. PLAB was classified as Cyclical & Capital-Intensive and is valued using Normalized Earnings × Cycle Multiple, built from PLAB's most recent reported fundamentals.

PLAB - Photronics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $55.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Cyclical & Capital-Intensive 80% confidence

Primary model: Normalized Earnings × Cycle Multiple

Valuation Signal Fair Value Mild

Trading 8.8% below fair value

Current Price $29.62

Bear Case $24.36 17.8% downside ($24.36 - $29.62) / $29.62 = -17.8% $2.03 × 12x

Fair Value $32.48 9.7% upside ($32.48 - $29.62) / $29.62 = 9.7% $2.03 × 16x

Bull Case $40.60 37.1% upside ($40.60 - $29.62) / $29.62 = 37.1% $2.03 × 20x

Adjust Assumptions

Cycle P/E Multiple

16.0x

Normalized EPS

2.03$

Key Value Driver

Through-cycle normalized EPS ($2.03)

Terminal Value % of EV

Implied Market Multiple 14.6x

Market is pricing in (growth)

Plain-Language Summary

Using 7-year normalized EPS of $2.03 at a 16x cycle multiple, the base-case value is $32.48 per share. P/TBV cross-check: 1.5x.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (11 analysts) $55.00

Analyst Range $55.00 – $55.00

Divergence from AlphaVal 41%

Warnings

ℹ This company has heavy ongoing investment costs. Valuation shortcuts that ignore those costs can make the stock look cheaper than it really is.

ℹ Wall Street's average price target is $55.00 (from 11 analysts). Our estimate is 41% below the consensus -- consider that gap carefully.

Key Risks

Standard 10-year DCF produces unreliable terminal values for cyclicals
'Cheap' P/E at cycle peak is the most common value trap — normalize first
Captive finance subsidiaries have different risk profiles from manufacturing